Condition
Bobath Therapy
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07238634Not ApplicableRecruiting
Effects of DMI vs Bobath on Neuromuscular Development in CP
NCT07006259Not ApplicableCompletedPrimary
Effect of Bobath Therapy on Balance Alterations in Patients With Multiple Sclerosis
NCT04536506Not ApplicableCompleted
Bobath and Vojta Therapy for DS
Showing all 3 trials